Cancer chemotherapy drug reverses Alzheimer’s symptoms in mice

A drug commonly used to treat cancer can restore memory and cognitive function in mice that display symptoms of Alzheimer’s disease, new research has found. The drug, Axitinib, inhibits growth of new blood vessels in the brain — a feature shared by both cancer tumors and Alzheimer’s disease. This hallmark represents a new target for Alzheimer’s therapies. Mice that underwent the therapy not only exhibited a reduction in blood vessels and other Alzheimer’s markers in their brains, they also performed remarkably well in tests designed to measure learning and memory.

Quelle: Sciencedaily

Calculating the path of cancer

Scientists are using a new mathematical tool to predict how combinations of genetic mutations cause different types of tumors.

Quelle: Sciencedaily

New mouse model unlocks drug testing of hormone-sensitive human breast cancer

Scientists have created mice with a hormone profile that causes growth and metastatic spread of implanted human breast tumors. Results show that the team created a new mouse breed, called NSG-Pro, that produces levels of human prolactin similar to those in patients with metastatic estrogen receptor-positive breast cancer.

Quelle: Sciencedaily

The immune system’s double agents

A new study examined the development of a glioblastoma cancerous tumor in animal models with a normal immune system, in order to best simulate the development of the tumor in humans.

Quelle: Sciencedaily

Powerful technique details brain tumors’ formidable resiliency

A team led by researchers  has profiled in unprecedented detail thousands of individual cells sampled from patients‘ brain tumors. The findings, along with the methods developed to obtain those findings, represent a significant advance in cancer research, and ultimately may lead to better ways of detecting, monitoring and treating cancers.

Quelle: Sciencedaily

Most cases of never-smokers’ lung cancer treatable with mutation-targeting drugs

Despite smoking’s well-known role in causing lung cancer, a significant number of patients who develop lung tumors have never smoked. While scientists are still working to understand what spurs cancer in so-called ’never-smokers,‘ a study suggests that 78% to 92% of lung cancers in patients who have never smoked can be treated with precision drugs already approved by the Food and Drug Administration to target specific mutations in a patient’s tumor.

Quelle: Sciencedaily

Looking beyond DNA to see cancer with new clarity

Researchers have mapped out how hundreds of mutations involved in two types of cancer affect the activity of proteins that are the ultimate actors behind the disease. The work points the way to identifying new precision treatments that may avoid the side effects common with much current chemotherapy.

Quelle: Sciencedaily

Safer treatment for deep-seated tumors

Scientists have detailed the effects of copper cysteamine, a next-generation cancer photo-drug.

Quelle: Sciencedaily

Scientists reverse pancreatic cancer progression in ‘time machine’ made of human cells

What makes pancreatic cancer so deadly is its covert and quick spread. Now, a ‚time machine‘ has shown a way to reverse the course of cancer before it spreads throughout the pancreas.

Quelle: Sciencedaily

New analytical technique helps researchers spot subtle differences in subcellular chemistry

Researchers can now rapidly isolate and chemically characterize individual organelles within cells. The new technique tests the limits of analytical chemistry and rapidly reveals the chemical composition of organelles that control biological growth, development and disease.

Quelle: Sciencedaily

Cell labelling method from microscopy adapted for use in whole-body imaging

Scientist have utilized so-called SNAP-tag technology to radioactively label cells in living organisms. In a proof-of-principle study they developed a SNAP-tag substrate equipped with the radioactive signal emitter fluorine-18 and used it to make tumor cells in the bodies of mice visible in PET images. The labeling method, already established in microscopy, opens up the prospect of studying cells with different imaging techniques and at different temporal stages — for example, when inflammation begins, continues and resolves again. This may help reveal more about how the functions of individual cells and entire organs are interconnected.

Quelle: Sciencedaily

New nanoparticle developed for intravenous cancer immunotherapy

Cancer immunotherapy seeks to turn ‚cold‘ tumors into ‚hot‘ tumors — those that respond to immunotherapy — by awakening and enlisting the body’s own immune system.

Quelle: Sciencedaily

Glioma subtype may hold the secret to the success of immunotherapies

A common mutation in gliomas sensitizes them to immunotherapy, a finding which researchers believe could have broader therapeutic implications for all glioma patients.

Quelle: Sciencedaily

How high-fat diets allow cancer cells to go unnoticed

The immune system relies on cell surface tags to recognize cancer cells. Researchers discovered mice who ate high-fat diets produced less of these tags on their intestinal cells, suppressing the ability of immune cells to identify and eliminate intestinal tumors. The high-fat diet also reduced the presence of certain bacteria in the mice’s gut, which normally helps maintain the production of these tags.

Quelle: Sciencedaily

Counting cells may shed light on how cancer spreads

Engineers developed a technique that allows them to measure the generation rate and half-life of circulating tumor cells (CTCs) in mice.

Quelle: Sciencedaily

Targeting a rare secondary cancer in children

Known as pediatric radiation-induced high-grade gliomas (RIGs), this specific type of brain tumor is caused by cranial radiation therapy for other cancers, most often brain cancers. They account for nearly 4% of all childhood brain tumor deaths, but there have not been many studies on RIGs and how to treat them.

Quelle: Sciencedaily

‘Research autopsy’ enable scientists study why certain cancer therapies stop working

A new research study turns cancer scientists into molecular detectives, searching for clues for why certain cancers are able to spread and evolve by studying tissues collected within hours of death.

Quelle: Sciencedaily

Sunlight exposure guidelines may need to be revised

Previously published solar exposure guidelines for optimal vitamin D synthesis based on a study of skin samples may need to be revised.

Quelle: Sciencedaily

Discovery of mechanics of drug targets for COVID-19

Researchers have discovered the working mechanism of potential drug targets for various diseases such as cancer, rheumatoid arthritis, and even COVID-19. The findings uncover the inner workings of cell receptors that are involved in cancer progression and inflammatory diseases.

Quelle: Sciencedaily

Radiation therapy reprograms heart muscle cells to younger state

New research suggests that radiation therapy can reprogram heart muscle cells to what appears to be a younger state, fixing electrical problems that cause a life-threatening arrhythmia without the need for a long-used, invasive procedure.

Quelle: Sciencedaily

Insights from our genome and epigenome will help prevent, diagnose and treat cancer

In 2020, an estimated 10 million people lost their lives to cancer. This devastating disease is underpinned by changes to our DNA — the instruction manual for all our cells.

Quelle: Sciencedaily

Lab grown tumor models could improve treatment for pancreatic cancer

An international team of scientists have created a three-dimensional (3D) pancreatic cancer tumour model in the laboratory, combining a bioengineered matrix and patient-derived cells that could be used to develop and test targeted treatments.

Quelle: Sciencedaily

About metabolism of a carcinoma cell

Most cancer cells utilize aerobic glycolysis irrespective of their tissue of origin. The alteration from oxidative phosphorylation to glycolysis – called the Warburg effect – is an universal phenomen and has now become a diagnostic tool for cancer detection.

Warburg O, Posener K, Negelein E. (1924) Über den Stoffwechsel der Carcinomzelle. Biochem Z. 152, 309–344.

The carcinogenic effect of various multi-walled carbon nanotubes (MWCNTs) after intraperitoneal injection in rats

Non-neoplastic histopathological findings in the abdominal cavity. A: High-power view of anti-podoplanin immunohistochemistry showing single MWCNT A (high dose) nanotubes in the tissue (arrows). B: High-power view of anti-podoplanin immunohistochemistry showing single asbestos fibers in the tissue (arrows). C: H & E, high-power view of granuloma induced by MWCNT A (low dose) nanotubes including single nanotube (arrow, 25×). D: H & E, high-power view of granuloma induced by asbestos including single fiber (arrow, 40×). Rittinghausen et al. Particle and Fibre Toxicology 2014 11:59   doi:10.1186/s12989-014-0059-z
Non-neoplastic histopathological findings in the abdominal cavity. A: High-power view of anti-podoplanin immunohistochemistry showing single MWCNT A (high dose) nanotubes in the tissue (arrows). B: High-power view of anti-podoplanin immunohistochemistry showing single asbestos fibers in the tissue (arrows). C: H & E, high-power view of granuloma induced by MWCNT A (low dose) nanotubes including single nanotube (arrow, 25×). D: H & E, high-power view of granuloma induced by asbestos including single fiber (arrow, 40×).
Rittinghausen et al. Particle and Fibre Toxicology 2014 11:59 doi:10.1186/s12989-014-0059-z

Susanne Rittinghausen, Anja Hackbarth, Otto Creutzenberg, Heinrich Ernst, Uwe Heinrich, Albrecht Leonhardt and Dirk Schaudien

Abstract

Background

Biological effects of tailor-made multi-walled carbon nanotubes (MWCNTs) without functionalization were investigated in vivo in a two-year carcinogenicity study. In the past, intraperitoneal carcinogenicity studies in rats using biopersistent granular dusts had always been negative, whereas a number of such studies with different asbestos fibers had shown tumor induction. The aim of this study was to identify possible carcinogenic effects of MWCNTs. We compared induced tumors with asbestos-induced mesotheliomas and evaluated their relevance for humans by immunohistochemical methods.

Methods

A total of 500 male Wistar rats (50 per group) were treated once by intraperitoneal injection with 109 or 5 × 109 WHO carbon nanotubes of one of four different MWCNTs suspended in artificial lung medium, which was also used as negative control. Amosite asbestos (108 WHO fibers) served as positive control. Morbid rats were sacrificed and necropsy comprising all organs was performed. Histopathological classification of tumors and, additionally, immunohistochemistry were conducted for podoplanin, pan-cytokeratin, and vimentin to compare induced tumors with malignant mesotheliomas occurring in humans.

Results

Treatments induced tumors in all dose groups, but incidences and times to tumor differed between groups. Most tumors were histologically and immunohistochemically classified as malignant mesotheliomas, revealing a predominantly superficial spread on the serosal surface of the abdominal cavity. Furthermore, most tumors showed invasion of peritoneal organs, especially the diaphragm. All tested MWCNT types caused mesotheliomas. We observed highest frequencies and earliest appearances after treatment with the rather straight MWCNT types A and B. In the MWCNT C groups, first appearances of morbid mesothelioma-bearing rats were only slightly later. Later during the two-year study, we found mesotheliomas also in rats treated with MWCNT D – the most curved type of nanotubes. Malignant mesotheliomas induced by intraperitoneal injection of different MWCNTs and of asbestos were histopathologically and immunohistochemically similar, also compared with mesotheliomas in man, suggesting similar pathogenesis.

Conclusion

We showed a carcinogenic effect for all tested MWCNTs. Besides aspect ratio, curvature seems to be an important parameter influencing the carcinogenicity of MWCNTs.

Continue reading „The carcinogenic effect of various multi-walled carbon nanotubes (MWCNTs) after intraperitoneal injection in rats“